d1000 Varejo Farma Participacoes SA
BOVESPA:DMVF3
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
5.2
8.38
|
Price Target |
|
We'll email you a reminder when the closing price reaches BRL.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
d1000 Varejo Farma Participacoes SA
Net Issuance of Debt
d1000 Varejo Farma Participacoes SA
Net Issuance of Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
d
|
d1000 Varejo Farma Participacoes SA
BOVESPA:DMVF3
|
Net Issuance of Debt
-R$70.5m
|
CAGR 3-Years
25%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Raia Drogasil SA
BOVESPA:RADL3
|
Net Issuance of Debt
-R$700.6m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-57%
|
CAGR 10-Years
N/A
|
||
Empreendimentos Pague Menos SA
BOVESPA:PGMN3
|
Net Issuance of Debt
R$24.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
||
Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3
|
Net Issuance of Debt
-R$71.5m
|
CAGR 3-Years
32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
d1000 Varejo Farma Participacoes SA
Glance View
D1000 Varejo Farma Participações SA engages in the operation of drugstore chains. The company is headquartered in Rio De Janeiro, Rio De Janeiro. The company went IPO on 2020-08-10. Through brands Drogasmil, Farmalife, Drogarias Tamoio and Drogaria Rosario, the Company sells drugs, dietary supplement and cosmetics, among others. The company operates around 300 stores in the States of Rio de Janeiro, Goias, Mato Grosso, Tocantins and Federal District. The firm is the Retail Business Unit of the Profarma Group.
See Also
What is d1000 Varejo Farma Participacoes SA's Net Issuance of Debt?
Net Issuance of Debt
-70.5m
BRL
Based on the financial report for Dec 31, 2023, d1000 Varejo Farma Participacoes SA's Net Issuance of Debt amounts to -70.5m BRL.
What is d1000 Varejo Farma Participacoes SA's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
5%
Over the last year, the Net Issuance of Debt growth was 23%. The average annual Net Issuance of Debt growth rates for d1000 Varejo Farma Participacoes SA have been 25% over the past three years , 5% over the past five years .